Geode Capital Management LLC boosted its stake in shares of VolitionRx Limited (NYSE:VNRX – Free Report) by 15.1% in the 3rd quarter, HoldingsChannel reports. The fund owned 730,448 shares of the ...

In this free webinar, explore the value of acute pain models for evaluating analgesic drug development. Attendees will learn how third molar extraction, abdominoplasty and bunionectomy can be ...

Halia Therapeutics, a biopharmaceutical company at the forefront of developing treatments for chronic inflammation and related disorders, announced today  that its leadership team will attend and ...

内华达州亨德森 - 目前股价为每股0.64美元的跨国表观遗传学公司VolitionRx Limited (NYSE AMERICAN: VNRX)在其2024年业务回顾中报告了过去一年的主要成就。根据 InvestingPro 的数据，该公司在过去十二个月内实现了97.5%的可观收入增长，尽管分析师指出预计今年该公司不会盈利。公司已将其Nu.Q® ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, has issued a Business Review of 2024, outlining its key highlights from the past year.

VolitionRx Limited (NYSEAMERICAN:VNRX – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0 ...

Highlights,VolitionRx focuses on epigenetics to aid in early cancer and disease detection.,Company’s market cap stands at $56 ...

Busy father and mother with small daughter in entrance hall indoors in the morning, leaving for work and nursery school. Moms handle the lion's share of the responsibility for organizing family ...

VolitionRX.的股票在纽约挂牌交易。 VolitionRX.的股票代码是什么？ VolitionRX.的股票代码是“VNRX。” VolitionRX.的市值是多少？ 截至今天，VolitionRX.的市值是58.38M。 VolitionRX.的每股收益(EPS)是多少？ VolitionRX.的每股收益(EPS)是-0.36。 VolitionRX.的下一财报日是哪天 ...